New era

Endoscopic treatment options in obesity-a paradigm shift

Jason Glass, Ahson Chaudhry, Muhammad S. Zeeshan, Zeeshan Ramzan

Research output: Contribution to journalReview article

Abstract

The prevalence of obesity continues to rise, and along with it comes a multitude of health-related consequences. The healthcare community has consistently struggled with providing treatment options to obese patients, in part due to the reluctance of patients in pursuing the more effective (yet invasive) surgical approaches such as sleeve gastrectomy and Rou-en-Y gastric bypass. On the other hand, the less invasive approach such as lifestyle/behavioral interventions and pharmacotherapy (Orlistat, Phenteramine, Phentermine/Topiramate, Locaserin, Naltrexon/Buproprion, and Liraglutide) have very limited efficacy, especially in the morbidly obese patients. Despite our best efforts, the epidemic of obesity continues to rise and pose enormous costs on our healthcare system and society. Bariatric endoscopy is an evolving field generated to combat this epidemic through minimally invasive techniques. These procedures can be performed in an ambulatory setting, are potentially reversible, repeatable, and pose less complications than their invasive surgical counterparts. These modalities are designed to alter gut metabolism by means of space occupation, malabsorption, or restriction. In this review we will discuss different bariatric endoscopic options (such as intragastric balloons, endoscopic sleeve gastroplasty, endoscopic aspiration therapies and gastrointestinal bypass sleeves), their advantages and disadvantages, and suggest a new paradigm where providers may start incorporating this modality in their treatment approach for obese patients.

Original languageEnglish (US)
Pages (from-to)4567-4579
Number of pages13
JournalWorld Journal of Gastroenterology
Volume25
Issue number32
DOIs
StatePublished - Aug 28 2019

Fingerprint

Obesity
Bariatrics
Phentermine
Gastroplasty
Delivery of Health Care
Gastric Bypass
Therapeutics
Gastrectomy
Endoscopy
Life Style
Costs and Cost Analysis
Drug Therapy
Health

Keywords

  • AspireAssist
  • Bariatric endoscopy
  • Bariatric medicine
  • Bariatrics
  • Endoscopic sleeve gastroplasty
  • Intragastric balloon
  • Obesity

ASJC Scopus subject areas

  • Gastroenterology

Cite this

New era : Endoscopic treatment options in obesity-a paradigm shift. / Glass, Jason; Chaudhry, Ahson; Zeeshan, Muhammad S.; Ramzan, Zeeshan.

In: World Journal of Gastroenterology, Vol. 25, No. 32, 28.08.2019, p. 4567-4579.

Research output: Contribution to journalReview article

Glass, Jason ; Chaudhry, Ahson ; Zeeshan, Muhammad S. ; Ramzan, Zeeshan. / New era : Endoscopic treatment options in obesity-a paradigm shift. In: World Journal of Gastroenterology. 2019 ; Vol. 25, No. 32. pp. 4567-4579.
@article{dbf791fb7e7941a99423b47fced8ec2f,
title = "New era: Endoscopic treatment options in obesity-a paradigm shift",
abstract = "The prevalence of obesity continues to rise, and along with it comes a multitude of health-related consequences. The healthcare community has consistently struggled with providing treatment options to obese patients, in part due to the reluctance of patients in pursuing the more effective (yet invasive) surgical approaches such as sleeve gastrectomy and Rou-en-Y gastric bypass. On the other hand, the less invasive approach such as lifestyle/behavioral interventions and pharmacotherapy (Orlistat, Phenteramine, Phentermine/Topiramate, Locaserin, Naltrexon/Buproprion, and Liraglutide) have very limited efficacy, especially in the morbidly obese patients. Despite our best efforts, the epidemic of obesity continues to rise and pose enormous costs on our healthcare system and society. Bariatric endoscopy is an evolving field generated to combat this epidemic through minimally invasive techniques. These procedures can be performed in an ambulatory setting, are potentially reversible, repeatable, and pose less complications than their invasive surgical counterparts. These modalities are designed to alter gut metabolism by means of space occupation, malabsorption, or restriction. In this review we will discuss different bariatric endoscopic options (such as intragastric balloons, endoscopic sleeve gastroplasty, endoscopic aspiration therapies and gastrointestinal bypass sleeves), their advantages and disadvantages, and suggest a new paradigm where providers may start incorporating this modality in their treatment approach for obese patients.",
keywords = "AspireAssist, Bariatric endoscopy, Bariatric medicine, Bariatrics, Endoscopic sleeve gastroplasty, Intragastric balloon, Obesity",
author = "Jason Glass and Ahson Chaudhry and Zeeshan, {Muhammad S.} and Zeeshan Ramzan",
year = "2019",
month = "8",
day = "28",
doi = "10.3748/wjg.v25.i32.4567",
language = "English (US)",
volume = "25",
pages = "4567--4579",
journal = "World Journal of Gastroenterology",
issn = "1007-9327",
publisher = "WJG Press",
number = "32",

}

TY - JOUR

T1 - New era

T2 - Endoscopic treatment options in obesity-a paradigm shift

AU - Glass, Jason

AU - Chaudhry, Ahson

AU - Zeeshan, Muhammad S.

AU - Ramzan, Zeeshan

PY - 2019/8/28

Y1 - 2019/8/28

N2 - The prevalence of obesity continues to rise, and along with it comes a multitude of health-related consequences. The healthcare community has consistently struggled with providing treatment options to obese patients, in part due to the reluctance of patients in pursuing the more effective (yet invasive) surgical approaches such as sleeve gastrectomy and Rou-en-Y gastric bypass. On the other hand, the less invasive approach such as lifestyle/behavioral interventions and pharmacotherapy (Orlistat, Phenteramine, Phentermine/Topiramate, Locaserin, Naltrexon/Buproprion, and Liraglutide) have very limited efficacy, especially in the morbidly obese patients. Despite our best efforts, the epidemic of obesity continues to rise and pose enormous costs on our healthcare system and society. Bariatric endoscopy is an evolving field generated to combat this epidemic through minimally invasive techniques. These procedures can be performed in an ambulatory setting, are potentially reversible, repeatable, and pose less complications than their invasive surgical counterparts. These modalities are designed to alter gut metabolism by means of space occupation, malabsorption, or restriction. In this review we will discuss different bariatric endoscopic options (such as intragastric balloons, endoscopic sleeve gastroplasty, endoscopic aspiration therapies and gastrointestinal bypass sleeves), their advantages and disadvantages, and suggest a new paradigm where providers may start incorporating this modality in their treatment approach for obese patients.

AB - The prevalence of obesity continues to rise, and along with it comes a multitude of health-related consequences. The healthcare community has consistently struggled with providing treatment options to obese patients, in part due to the reluctance of patients in pursuing the more effective (yet invasive) surgical approaches such as sleeve gastrectomy and Rou-en-Y gastric bypass. On the other hand, the less invasive approach such as lifestyle/behavioral interventions and pharmacotherapy (Orlistat, Phenteramine, Phentermine/Topiramate, Locaserin, Naltrexon/Buproprion, and Liraglutide) have very limited efficacy, especially in the morbidly obese patients. Despite our best efforts, the epidemic of obesity continues to rise and pose enormous costs on our healthcare system and society. Bariatric endoscopy is an evolving field generated to combat this epidemic through minimally invasive techniques. These procedures can be performed in an ambulatory setting, are potentially reversible, repeatable, and pose less complications than their invasive surgical counterparts. These modalities are designed to alter gut metabolism by means of space occupation, malabsorption, or restriction. In this review we will discuss different bariatric endoscopic options (such as intragastric balloons, endoscopic sleeve gastroplasty, endoscopic aspiration therapies and gastrointestinal bypass sleeves), their advantages and disadvantages, and suggest a new paradigm where providers may start incorporating this modality in their treatment approach for obese patients.

KW - AspireAssist

KW - Bariatric endoscopy

KW - Bariatric medicine

KW - Bariatrics

KW - Endoscopic sleeve gastroplasty

KW - Intragastric balloon

KW - Obesity

UR - http://www.scopus.com/inward/record.url?scp=85071724917&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85071724917&partnerID=8YFLogxK

U2 - 10.3748/wjg.v25.i32.4567

DO - 10.3748/wjg.v25.i32.4567

M3 - Review article

VL - 25

SP - 4567

EP - 4579

JO - World Journal of Gastroenterology

JF - World Journal of Gastroenterology

SN - 1007-9327

IS - 32

ER -